Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway

Non-alcoholic fatty liver disease (NAFLD), ranging from non-alcoholic fatty liver to non-alcoholic steatohepatitis, can be prevalent in patients with type 2 diabetes mellitus (T2DM). However, no antidiabetic drug has been approved for the treatment of NAFLD in T2DM patients. Multiple daily injection...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Rui, Lin, Chuman, Cheng, Yanzhen, Zhuo, Xiaoyun, Li, Qinghua, Xu, Wen, Zhao, Liang, Yang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970416/
https://www.ncbi.nlm.nih.gov/pubmed/33746742
http://dx.doi.org/10.3389/fphar.2020.600175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970416/
https://www.ncbi.nlm.nih.gov/pubmed/33746742
http://dx.doi.org/10.3389/fphar.2020.600175

Ejemplares similares